Washington Post, High Success Rate in Study Lends Promise to New Treatment
Hepatitis C is estimated to to infect 4 million people in the US and 170 million worldwide and is the leading cause of liver transplants.
A German study found that 42-43 newly infected patients who received treatment became virus free from Hepatitis C. The treatment is a six months of interferon alfa-2b and ribavirin. Similar studies have been done but this is the most successful to date.
This success highlights the need for greater diagnosis. Because Hepatitis C is symptomatic in fewer then 20% of the cases. Diagnosis and treatment are critical early on to increase success.The estimated cost of the treatment is 6,000 and the resulting therapy 24,000.
Previous Article
Return to Animal Physiology Forum
If you would like to post a response to this article, use this form.
Animal Physiology Forum